Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review
Oral Diseases · 15.11.2026
DOI: 10.1111/odi.70573 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oral Diseases, online erschienen am 15.11.2026. Verfasst von Camila Barcellos Calderipe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Objective
To identify the types of cancer and the corresponding screening methods evaluated in randomized controlled trials (RCTs), with a primary focus on situating oral cancer screening within the RCT‐based body of evidence.
Methods
This review followed the PRISMA‐ScR guidelines. PubMed, Web of Science, Embase, Scopus, LILACS, ProQuest, and Google Scholar were searched without date restrictions for studies in English, Spanish, or Portuguese. Eligible studies were RCTs primarily evaluating cancer screening methods (clinical, imaging, endoscopic, laboratory, molecular/serological, or self‐examination). Data were synthesized as means and frequencies.
Results
Nine cancer types and 33 distinct screening methods were identified across 97 cancer screenings in 91 RCTs spanning 57 years. Oral cancer ranked last, with only one RCT evaluating a single method, oral visual inspection, the fewest of any cancer type. By comparison, colorectal cancer was the most frequently investigated ( n = 22/22.7%), followed by breast cancer ( n = 21/21.6%) and lung cancer ( n = 18/18.6%), with five, six, and four screening methods evaluated, respectively.
Conclusion
These findings map the RCT landscape in cancer screening, revealing marked disparities in evidence across cancer types and identifying oral cancer as the most limited. Further RCTs are urgently needed to strengthen the evidence base and support effective oral cancer screening programs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.
- Faculty of Dental, Oral and Craniofacial Sciences, King's College London and WHO Collaborating Centre for Oral Cancer, London, UK.
ORCID-Profile: Camila Barcellos Calderipe, Caique Mariano Pedroso, Márcio Ajudarte Lopes, Saman Warnakulasuriya, Alan Roger Santos-Silva
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Calderipe, C. B., Pedroso, C. M., Lopes, M. A., Warnakulasuriya, S., & Santos-Silva, A. R. (2026). Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review. Oral Diseases. https://doi.org/10.1111/odi.70573
Vancouver
Calderipe CB, Pedroso CM, Lopes MA, Warnakulasuriya S, Santos-Silva AR. Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review. Oral Diseases. 2026. doi:10.1111/odi.70573
BibTeX
@article{Calderipe2026,
author = {Calderipe, Camila Barcellos and Pedroso, Caique Mariano and Lopes, Márcio Ajudarte and Warnakulasuriya, Saman and Santos-Silva, Alan Roger},
title = {Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review},
journal = {Oral Diseases},
year = {2026},
doi = {10.1111/odi.70573}
}
EUVIMED